Comparison of the effects of the levonorgestrel-releasing intrauterine system (Mirena®) and depot-medroxyprogesterone acetate (Depo-Provera®) on subendometrial microvascularisation and uterine artery blood flow

被引：7
|
作者：
Dane, Banu [1 ]
Akca, Aysu [1 ]
Dane, Cem [1 ]
Evcimen, Serap [1 ]
Cetin, Ahmet [1 ]
机构：
[1] Haseki Training & Res Hosp, Dept Obstet & Gynaecol, Istanbul, Turkey
来源：
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE | 2009年 / 14卷 / 03期
关键词：
Levonorgestrel-intrauterine system; Subendometrial vascularisation; Depot-medroxyprogesterone acetate; Bleeding disorders; USERS; CONTRACEPTIVES; PROGESTERONE; CYCLOFEM(R); EXPRESSION; NORPLANT; DEVICE; WOMEN;
D O I：
10.1080/13625180902850047
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Objective To compare the effects of the levonorgestrel-intrauterine system (LNG-IUS) and depot-medroxyprogesterone acetate (DMPA) on subendometrial vascularisation and uterine artery blood flow. Study design The trial compared 25 patients wearing a LNG-IUS and 25 patients receiving DMPA. The subendometrial blood flow was evaluated using power Doppler analysis; the pulsatility index (PI) and resistance index (RI) in the uterine artery and spiral arteries were evaluated with spectral Doppler. Results The PI and RI of the uterine artery and endometrial thickness did not differ significantly between the two groups. The subendometrial vascularisation was lower and the PI in the spiral arteries was higher in DMPA-users. Conclusion In spite of a similar prevalence of bleeding disturbances, the effects of DMPA and the LNG-IUS on the subendometrial microvascularisation differ.
引用
收藏
页码：240 / 244
页数：5
相关论文
共 17 条
  • [1] The effect of the levonorgestrel-releasing intrauterine system and the copper intrauterine device on subendometrial microvascularization and uterine artery blood flow
    Jimenez, Mirela Foresti
    Arbo, Elisangela
    Vetori, Daniela
    de Freitas, Fernando Monteiro
    Lahorgue Cunha-Filho, Joao Sabino
    FERTILITY AND STERILITY, 2008, 90 (05) : 1574 - 1578
  • [2] Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia
    Behnamfar, Fariba
    Ghahiri, Attaollah
    Tavakoli, Marzieh
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 (08): : 686 - 690
  • [3] Comparing Levonorgestrel-releasing intrauterine system (Mirena) and medroxyprogesterone acetate as a therapy for endometrial hyperplasia
    Behnamfar, F.
    Ghahiri, A.
    Tavakoli, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 961 - 961
  • [4] Weight variation in users of depot-medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine system and a copper intrauterine device for up to ten years of use
    Modesto, Waleska
    Silva dos Santos, Priscila de Nazare
    Correia, Vinicius Machado
    Borges, Luiza
    Bahamondes, Luis
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2015, 20 (01): : 57 - 63
  • [5] Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome
    Brooks, J. Paul
    Edwards, David J.
    Blithe, Diana L.
    Fettweis, Jennifer M.
    Serrano, Myrna G.
    Sheth, Nihar U.
    Strauss, Jerome F., III
    Buck, Gregory A.
    Jefferson, Kimberly K.
    CONTRACEPTION, 2017, 95 (04) : 405 - 413
  • [6] A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives
    Cromer, BA
    Blair, JM
    Mahan, JD
    Zibners, L
    Naumovski, Z
    JOURNAL OF PEDIATRICS, 1996, 129 (05): : 671 - 676
  • [7] Levonorgestrel-releasing intrauterine system (Mirena®) and Depot medroxyprogesterone acetate (Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: A randomised controlled trial
    Wong, Alice Yuen Kwan
    Tang, Lawrence Chang Hung
    Chin, Robert Kien Howe
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2010, 50 (03): : 273 - 279
  • [8] Subendometrial microvascularization and uterine artery blood flow in IUD-induced side effects (levonorgestrel intrauterine system and copper intrauterine device)
    Jimenez, Mirela F.
    Vetori, Daniela
    Fagundes, Paulo A. P.
    de Freitas, Fernando M.
    Cunha-Filho, Joao S. L.
    CONTRACEPTION, 2008, 78 (04) : 324 - 327
  • [9] Letter in response to Levonorgestrel-releasing intrauterine system (Mirena®) and Depot medroxyprogesterone acetate (Depo-Provera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised trial by Wong AYK, Tang LCH, Chin RKH Aust N Z J Obstet Gynaecol 2010; 50 (3): 273-279
    Basu, Abhijit
    Haran, Mano
    Nair, Anil
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2011, 51 (01): : 97 - 98
  • [10] RETRACTION: Effects of the levonorgestrel-releasing intrauterine system versus the copper intrauterine device on uterine artery Doppler indices
    Khamees, Rasha E.
    Kishk, Eman A.
    Mahmoud, Sally S.
    Said, Mamdouh E.
    Taha, Omima T.
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2022, 27 (05): : 436 - 436
12